Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

3.380 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

July 30, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting

May 21, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

April 30, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

April 21, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

April 20, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026

March 18, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

March 17, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline

February 03, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026

January 12, 2026

From Bicycle Therapeutics plc

Via Business Wire

The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub

December 23, 2025

The global financial landscape is witnessing a seismic shift as international corporations increasingly abandon their home markets to "onshore" in the United States. At the heart of this movement is...

Via MarketMinute

Topics Economy Initial Public Offering

Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline

December 16, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

November 12, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

October 30, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Strengthens Board of Directors with New Appointments

September 08, 2025

From Bicycle Therapeutics plc

Via Business Wire

4 Analysts Assess Bicycle Therapeutics: What You Need To Know ↗

August 12, 2025

Via Benzinga

Bicycle (BCYC) Q2 Revenue Falls 69% ↗

August 08, 2025

Via The Motley Fool

Topics Intellectual Property

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

August 08, 2025

From Bicycle Therapeutics plc

Via Business Wire

Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews ↗

July 17, 2025

Via Benzinga

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 02, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 03, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

May 22, 2025

From Bicycle Therapeutics

Via Business Wire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 05, 2025

From Bicycle Therapeutics plc

Via Business Wire

A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts ↗

May 02, 2025

Via Benzinga

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

May 01, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

April 29, 2025

From Bicycle Therapeutics plc

Via Business Wire

Analyst Expectations For Bicycle Therapeutics's Future ↗

April 09, 2025

Via Benzinga

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 02, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

April 01, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

March 27, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 05, 2025

From Bicycle Therapeutics plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.